Combinations of BTZ with other drugs (e.g., IMiDs, panobinostat, or monoclonal antibodies) also induced response in MM patients after failing previous treatment with BTZ.12, 13, 14, 15, 16. This evidence concerns the gene CASC3 and Miyoshi myopathy.